Genvec Inc (GNVC)

6.68
0.30 4.30
NASDAQ : Health Care
Prev Close 6.98
Open 7.05
Day Low/High 6.68 / 7.05
52 Wk Low/High 0.35 / 3.69
Volume 8.12K
Avg Volume 34.60K
Exchange NASDAQ
Shares Outstanding 2.27M
Market Cap 15.69M
EPS -2.80
Div & Yield N.A. (N.A)

Latest News

INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of GenVec, Inc. And Encourages Investors To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of GenVec,...

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of GenVec, Inc. And Encourages Investors To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of GenVec,...

Intrexon To Acquire GenVec To Expand Industry-Leading Gene Delivery Platform

Intrexon To Acquire GenVec To Expand Industry-Leading Gene Delivery Platform

GenVec's AdenoVerse™ to be Integrated into Intrexon's Proprietary Synthetic Biology Platform

This Small-Cap Rotation Is Unconvincing

This Small-Cap Rotation Is Unconvincing

Traders, pressed to find some action, are chasing certain things to a ridiculous extent.

GenVec Signs Option Agreement For Gene Editing And Cell Targeting Technology From Washington University In St. Louis

GenVec Signs Option Agreement For Gene Editing And Cell Targeting Technology From Washington University In St. Louis

Provides Exclusive Access to Gene Editing and Pulmonary Endothelial Targeting Technologies

GenVec To Present At 2016 Cell & Gene Meeting On The Mesa

GenVec To Present At 2016 Cell & Gene Meeting On The Mesa

Wednesday, October 5th, 11 a.m. PDT/2:00 pm EDT

FDA Lifts Clinical Hold On CGF166

FDA Lifts Clinical Hold On CGF166

7 Stocks Under $10 Spiking Toward Big Gains

7 Stocks Under $10 Spiking Toward Big Gains

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits

GenVec Provides Update On Hearing Loss Clinical Program

GenVec Provides Update On Hearing Loss Clinical Program

Data Safety Monitoring Board Recommends Trial Continue

5 Stocks Under $10 Set to Soar Higher

These five stocks trading for less than $10 a share are within range of triggering breakout trades.

GenVec Provides Investor Update

GenVec Provides Investor Update

Highlights Ongoing Initiatives Involving the AdenoVerse™ Gene Delivery Platform

A Lack of News and Buzz at 'JPM16' Sinks Biotech Stocks

A Lack of News and Buzz at 'JPM16' Sinks Biotech Stocks

Biotech stocks large and small were plummeting as 2016's painful start began to turn torturous.

GenVec Receives Notice Of Allowance For Patent Application Providing Broad Protection Of Its Gorilla Adenovectors

GenVec Receives Notice Of Allowance For Patent Application Providing Broad Protection Of Its Gorilla Adenovectors

Composition of Matter Protection for Proprietary Gorilla Vectors Expansion of AdenoVerse™ Platform Provides Multiple Opportunities for New Applications

GenVec Highlights Gorilla Adenovectors At Vaccines R&D-2015 Conference

GenVec Highlights Gorilla Adenovectors At Vaccines R&D-2015 Conference

Presentation Includes Emerging Data from Malaria Collaboration with NIAID

GenVec To Present At 2015 Stem Cell Meeting On The Mesa

GenVec To Present At 2015 Stem Cell Meeting On The Mesa

Wednesday, October 7th, 5:15 pm Pacific/8:15 pm EDT

GenVec To Present At The Jefferies Healthcare Conference

GenVec To Present At The Jefferies Healthcare Conference

Webcast Presentation Scheduled for Thursday, June 4th at 11 a.m. EDT